Biotech
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against CorMedix Inc. (“CorMedix” or the “Company”) (NASDAQ: CRMD) in the United States more...
Biotech
CRMD Final Deadline Alert: Rosen, Skilled Investor Counsel, Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important September 20 Deadline in Securities Class Action – CRMD
New York, New York–(Newsfile Corp. – September 17, 2021) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8, 2020 and May more...
Biotech
CRMD INVESTOR LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against CorMedix Inc.
NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a Lead Plaintiff motion in a securities class action lawsuit that more...
Biotech
Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion’s DNA-based Vaccine
E xpands GEN-1 P rogram C ollaboration to Add C linical and C ommercial B atches of I nvestigational V accine LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: more...
Biotech
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CorMedix Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 17, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CorMedix Inc. (“CorMedix” or “the Company”) (NASDAQ:CRMD) more...
Biotech
Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit
CHESTERBROOK, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced more...
Biotech
EyePoint Pharmaceuticals to Present Data at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting
WATERTOWN, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that more...
Biotech
CRMD FINAL DEADLINE MONDAY: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important September 20 Deadline in Securities Class Action – CRMD
CRMD FINAL DEADLINE MONDAY: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important September 20 Deadline in Securities Class Action – CRMD PR Newswire NEW YORK , more...
Biotech
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. more...
Biotech
BeiGene (BGNE) Scores Third FDA Nod for Brukinsa in Lymphoma
BeiGene, Ltd. BGNE announced that the FDA has granted an accelerated approval to its marketed drug, Brukinsa (zanubrutinib), for a new indication. The drug has been approved for the treatment of relapsed or refractory (R/R) more...